RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis

scientific article published on 30 October 2009

RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BONE.2009.10.028
P698PubMed publication ID19879986

P50authorClaes OhlssonQ60502755
Andrej TarkowskiQ100328748
P2093author name stringMaria Bokarewa
Margareta Verdrengh
Marina Stolina
P433issue3
P921main subjectStaphylococcus aureusQ188121
P304page(s)752-758
P577publication date2009-10-30
P1433published inBoneQ15755003
P1476titleRANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis
P478volume46

Reverse relations

cites work (P2860)
Q46499539Curcumin inhibits inflammatory response and bone loss during experimental periodontitis in rats
Q36245810Estradiol ameliorates arthritis and protects against systemic bone loss in Staphylococcus aureus infection in mice
Q40209277Exposure to fermentation supernatant of Staphylococcus aureus accelerated dedifferentiation of chondrocytes and production of antimicrobial peptides
Q92405045Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation
Q35766784RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease
Q54413513SIRT1 modulates high‐mobility group box 1‐induced osteoclastogenic cytokines in human periodontal ligament cells
Q36054527Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
Q38858001Transglutaminase 2 up-regulation is associated with RANKL/OPG pathway in cultured HPDL cells and THP-1-differentiated macrophages

Search more.